October 21, 2024 at 9:58 am

IceCure Wins U.S. Patent for Next-Generation Cryoablation System; Stock Trading Up 10%

IceCure Medical Ltd. (Nasdaq: ICCM) has secured a Notice of Allowance from the U.S. Patent and Trademark Office for its innovative “Cryogenic System Connector.” This patented technology is a critical component of IceCure’s next-generation XSense™ cryoablation system, which uses liquid nitrogen to freeze and destroy tumors as an alternative to surgical removal. The XSense™ system,… [Read More]
October 21, 2024 at 8:54 am

Breakthrough Preclinical Results: MIRA Pharmaceuticals’ Ketamir-2 Surpasses Leading Neuropathic Pain Treatments

MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) reports that its novel oral ketamine analog, Ketamir-2, has outperformed FDA-approved neuropathic pain treatments Gabapentin and Pregabalin in a recent preclinical study. Conducted on female rats with nerve-induced neuropathy, the study showed that low doses of Ketamir-2 provided significant pain relief by Day 15. By Day 22, Ketamir-2 was up… [Read More]
October 18, 2024 at 4:19 pm

The Rise in Netflix Subscriptions Slows as the Clampdown on Password Sharing Comes into Play

Netflix (NFLX, Financial) recently announced a dip in its net subscription numbers over the summer, following a significant increase last year tied to actions against account sharing. Subscriber growth in the third quarter was 5.1 million, marking a 42% decrease from the same time last year. However, even with slower monthly subscriber growth, Netflix’s financial… [Read More]
October 18, 2024 at 11:04 am

Immutep Advances First-in-Human Phase I Study of IMP761 to Dose Escalation Phase

Immutep Limited (ASX: IMM; NASDAQ: IMMP), a clinical-stage biotechnology company focused on LAG-3 immunotherapies, announced that its first-in-human Phase I study of IMP761 has progressed to the dose escalation phase. The study, conducted at the Centre for Human Drug Research (CHDR) in the Netherlands, involves administering increasing doses of IMP761 to healthy volunteers after the… [Read More]
October 18, 2024 at 10:54 am

Safety and AI: Knightscope Signs Additional Contracts with Healthcare Clients

A leading innovator in robotics and artificial intelligence (AI) technologies with a focus on public safety Knightscope, Inc. (KSCP), announced the signing of two new contracts for its Full Service Maintenance Plan (FSMP) with existing healthcare clients in Connecticut and New York. Healthcare facilities across the U.S. face major challenges in ensuring the safety and… [Read More]
October 17, 2024 at 11:11 am

Poseida Therapeutics Announces New CAR-T Development Candidate Under Roche Collaboration

Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell therapy company, has announced the nomination of a new allogeneic CAR-T therapy candidate as part of its collaboration with Roche. This new dual CAR-T candidate targets hematologic cancers, including multiple myeloma, a common and incurable blood cancer responsible for 12,000 deaths in the U.S. in 2021. With… [Read More]
October 17, 2024 at 10:59 am

OKYO Pharma Initiates Phase 2 Trial for Neuropathic Corneal Pain Treatment

OKYO Pharma (NASDAQ: OKYO) has begun patient recruitment for its Phase 2 clinical trial to evaluate OK-101 for treating neuropathic corneal pain (NCP), a rare condition with no FDA-approved treatments. NCP is a chronic pain disorder affecting the eyes, face, or head, believed to result from nerve damage and inflammation. The trial will enroll 48… [Read More]
October 17, 2024 at 10:16 am

ChargePoint (CHPT) Powers Up Fleet and Home Charging with New $699 Commercial Charger and Streamlined Installation

ChargePoint (NYSE: CHPT), a leading provider of networked charging solutions for electric vehicles (EVs), today announced the launch of a low-cost commercial vehicle charger, the CPF50, priced at $699. This entry-level solution is designed to make fleet electrification more accessible for small businesses and larger fleets alike. Paired with ChargePoint’s fleet management software, it provides… [Read More]
October 17, 2024 at 10:12 am

Gaming Gone International: Turtle Beach (HEAR) Expands Into Canadian and Latin American Markets

The leading maker of gaming accessories Turtle Beach (HEAR) is expanding its reach in key international markets, including Canada and Latin America. In Canada, Turtle Beach’s popular wireless headsets—Stealth™ 700, Stealth 600, and Stealth 500—along with the Atlas Air™ wireless PC headset, Vulcan II TKL Pro PC gaming keyboard, and Burst™ II Air PC gaming… [Read More]